This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UiPath (PATH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed at $32.40 in the latest trading session, marking a +0.97% move from the prior day.
Alteryx (AYX) Acquires Trifacta, Boosts Cloud Solutions Footing
by Zacks Equity Research
Alteryx (AYX) acquires Trifacta to ramp up the development of the integrated end-to-end analytics automation platform in cloud computing.
Opportunities Are Ripening In The Face Of Fear - stage_V3
by David Bartosiak
This fear-driven sell-off should be seen as an opportunity to pick up well positioned stocks at a discount
Opportunities Are Ripening In The Face Of Fear - stage
by David Bartosiak
This fear-driven sell-off should be seen as an opportunity to pick up well positioned stocks at a discount
Stage - Opportunities Are Ripening In The Face Of Fear
by Sheraz Mian
This fear-driven sell-off should be seen as an opportunity to pick up well positioned stocks at a discount
Opportunities Are Ripening In The Face Of Fear
by Daniel Laboe
This fear-driven sell-off should be seen as an opportunity to pick up well positioned stocks at a discount
UiPath (PATH) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
UiPath's (PATH) third-quarter 2022 earnings are expected to have declined sequentially, while revenues are likely to have improved.
UiPath (PATH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed the most recent trading day at $49.49, moving -0.36% from the previous trading session.
UiPath (PATH) Stock Moves -0.3%: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed the most recent trading day at $53.54, moving -0.3% from the previous trading session.
Applying A Barbell Investment Strategy To Protect Against Stagflation
by Daniel Laboe
An inclination towards this strategy can be seen with the bids for exceptionally safe dividend drivers like utilities, real estate, & consumer staples, combined with a growing penchant for speculative innovation-fueled equities.
SL Green (SLG) Secures 91% at One Vanderbilt, Stock Rallies
by Zacks Equity Research
SL Green's (SLG) new 26,363 -sq-ft lease with UiPath at One Vanderbilt Avenue brings the property to 91% leased.
Equity Market Remains Indecisive Going Into This Shortened Trading Week
by Daniel Laboe
The public equity markets were quiet going into the long holiday weekend, as the irony of a bad jobs report on the eve of Labor Day weekend reverberated in investors' indecision on Friday (and into Tuesday)
UiPath (PATH) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
UiPath's (PATH) second-quarter 2022 earnings and revenues are expected to have declined sequentially.
UiPath (PATH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed at $61.55 in the latest trading session, marking a -0.79% move from the prior day.
UiPath (PATH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed at $63.85 in the latest trading session, marking a -1.65% move from the prior day.
UiPath (PATH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed the most recent trading day at $60.37, moving -0.3% from the previous trading session.
UiPath (PATH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UiPath (PATH) closed the most recent trading day at $62, moving -0.24% from the previous trading session.
IPOs See Best Q2 in 2 Decades: ETFs to Ride the Boom
by Sweta Killa
The U.S. IPO market set another milestone in the second quarter with 113 IPOs raising $39.9 billion, marking the busiest quarter in over two decades.
High-Growth Stocks Jump Back Into Investors' Favor
by Daniel Laboe
The short-term bottom for next-generation enterprises is in, and high multiple stocks are returning to investors' favor.